Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00984
|
|||||
| Drug Name |
Warfarin
|
|||||
| Synonyms |
(-)-Warfarin; (S)-Warfarin; 200 coumarin; Arab Rat Death; Arab rat deth; Athrombine-K; Brumolin; CBKinase1_000192; CBKinase1_012592; CO-Rax; Choice; Choice (TN); Coumadin; Coumadin (TN); Coumafen; Coumafene; Coumafene [French]; Coumaphen; Coumaphene; Coumarins; Coumefene; Cov-R-Tox; D-Con; Dethmor; Dethnel; Dicusat E; Eastern states duocide; Fasco fascrat powder; Frass-Ratron; Jantoven (TN); Kumader; Kumadu; Kumatox; Kypfarin; Latka 42; Latka 42 [Czech]; Liqua-tox; Maag Rattentod Cum; Mar-Frin; Marevan (TN); Martin's mar-frin; Maveran; Mouse pak; PS104_SUPELCO; Panwarfin; Place-pax; Prothromadin; RAX; Rac-Warfarin; Rat & mice bait; Rat-B-gon; Rat-Gard; Rat-Kill; Rat-Mix; Rat-Ola; Rat-Trol; Rat-a-way; Rat-o-cide #2; Ratorex; Ratoxin; Ratron; Ratron G; Rats-no-more; Ratten-Koederrohr; Rattenstreupulver Neu Schacht; Rattenstreupulver new schacht; Rattentraenke; Rattunal; Ro-Deth; Rodafarin; Rodafarin C; Rodex blox; Rosex; Rough & ready mouse mix; Sofarin; Solfarin; Sorexa plus; Spray-trol brand roden-trol; Temus W; Tox-hid; Twin light rat away; Vampirinip II; Vampirinip iii; W.A.R.F. 42; WARF compound 42; Waran (TN); Warf 10; Warf 42; Warfarat; Warfarin (INN); Warfarin (and salts of); Warfarin Q; Warfarin [BSI:ISO]; Warfarin [INN:BAN]; Warfarin plus; Warfarin plus [discontinued]; Warfarin titrated to an INR of 2.5-3.0; Warfarin(R); Warfarina; Warfarina [INN-Spanish]; Warfarine; Warfarine [INN-French]; Warfarine [ISO-French]; Warfarinum; Warfarinum [INN-Latin]; Warficide; Zoocoumarin; Zoocoumarin [Netherlands and USSR]; Zoocoumarin [Russian]
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Atrial fibrillation [ICD11: BC81.3] | Approved | [1] | |||
| Therapeutic Class |
Anticoagulants
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C19H16O4
|
|||||
| Canonical SMILES |
CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O
|
|||||
| InChI |
InChI=1S/C19H16O4/c1-12(20)11-15(13-7-3-2-4-8-13)17-18(21)14-9-5-6-10-16(14)23-19(17)22/h2-10,15,21H,11H2,1H3
|
|||||
| InChIKey |
PJVWKTKQMONHTI-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 81-81-2
|
|||||
| Pharmaceutical Properties | Molecular Weight | 308.3 | Topological Polar Surface Area | 63.6 | ||
| Heavy Atom Count | 23 | Rotatable Bond Count | 4 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 4 | |||
| XLogP |
2.7
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
ChEBI:10034
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | OATP1B3 | Transporter Info | Organic anion transporting polypeptide 1B3 | Substrate | [2] | |
| References | ||||||
| 1 | Warfarin was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Bosentan is a substrate of human OATP1B1 and OATP1B3: inhibition of hepatic uptake as the common mechanism of its interactions with cyclosporin A, rifampicin, and sildenafil. Drug Metab Dispos. 2007 Aug;35(8):1400-7. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.